- Home
- SLDB vs TCMD Comparison
SLDB vs TCMD Comparison
Compare SLDB & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLDB
- TCMD
- Stock Information
- Founded
- SLDB 2013
- TCMD 1995
- Country
- SLDB United States
- TCMD United States
- Employees
- SLDB N/A
- TCMD N/A
- Industry
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- TCMD Medical/Dental Instruments
- Sector
- SLDB Health Care
- TCMD Health Care
- Exchange
- SLDB Nasdaq
- TCMD Nasdaq
- Market Cap
- SLDB 366.2M
- TCMD 337.0M
- IPO Year
- SLDB 2018
- TCMD 2016
- Fundamental
- Price
- SLDB $3.45
- TCMD $13.60
- Analyst Decision
- SLDB Strong Buy
- TCMD Hold
- Analyst Count
- SLDB 10
- TCMD 2
- Target Price
- SLDB $18.10
- TCMD $18.00
- AVG Volume (30 Days)
- SLDB 1.2M
- TCMD 215.0K
- Earning Date
- SLDB 03-06-2025
- TCMD 05-05-2025
- Dividend Yield
- SLDB N/A
- TCMD N/A
- EPS Growth
- SLDB N/A
- TCMD N/A
- EPS
- SLDB N/A
- TCMD 0.70
- Revenue
- SLDB N/A
- TCMD $292,984,000.00
- Revenue This Year
- SLDB N/A
- TCMD $10.71
- Revenue Next Year
- SLDB $717.65
- TCMD $8.80
- P/E Ratio
- SLDB N/A
- TCMD $18.89
- Revenue Growth
- SLDB N/A
- TCMD 6.76
- 52 Week Low
- SLDB $2.88
- TCMD $11.12
- 52 Week High
- SLDB $12.95
- TCMD $21.10
- Technical
- Relative Strength Index (RSI)
- SLDB 32.52
- TCMD 42.96
- Support Level
- SLDB $4.12
- TCMD $12.69
- Resistance Level
- SLDB $4.44
- TCMD $13.94
- Average True Range (ATR)
- SLDB 0.37
- TCMD 0.42
- MACD
- SLDB -0.20
- TCMD 0.11
- Stochastic Oscillator
- SLDB 0.87
- TCMD 59.48
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.